Acurx Pharmaceuticals, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-109698
- Form type
- 10-Q
- CIK
- 0001736243
- Primary document
- https://www.sec.gov/Archives/edgar/data/1736243/000110465925109698/acxp-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Acurx Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-6.5M | - | - |
| Net Income | $-6.4M | - | - |
| Eps Basic | -5.01 | - | - |
| Eps Diluted | -5.01 | - | - |
| Total Assets | $6.1M | - | - |
| Total Liabilities | $2.5M | - | - |
| Shareholders Equity | $3.6M | - | - |
| Operating Cash Flow | $-5.6M | - | - |